ZA984920B - Therapeutically active compositions - Google Patents

Therapeutically active compositions

Info

Publication number
ZA984920B
ZA984920B ZA984920A ZA984920A ZA984920B ZA 984920 B ZA984920 B ZA 984920B ZA 984920 A ZA984920 A ZA 984920A ZA 984920 A ZA984920 A ZA 984920A ZA 984920 B ZA984920 B ZA 984920B
Authority
ZA
South Africa
Prior art keywords
therapeutically active
active compositions
compositions
therapeutically
active
Prior art date
Application number
ZA984920A
Other languages
English (en)
Inventor
Fiona Kate Statham
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA984920B publication Critical patent/ZA984920B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA984920A 1997-06-10 1998-06-18 Therapeutically active compositions ZA984920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions

Publications (1)

Publication Number Publication Date
ZA984920B true ZA984920B (en) 1999-07-01

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984920A ZA984920B (en) 1997-06-10 1998-06-18 Therapeutically active compositions

Country Status (17)

Country Link
US (1) US6201014B1 (zh)
EP (1) EP0988028B1 (zh)
JP (1) JP2002513418A (zh)
KR (1) KR20010013618A (zh)
CN (1) CN1198594C (zh)
AR (1) AR012960A1 (zh)
AT (1) ATE262892T1 (zh)
AU (1) AU737606B2 (zh)
BR (1) BR9809994A (zh)
CA (1) CA2291796C (zh)
DE (1) DE69822822T2 (zh)
GB (3) GB9711962D0 (zh)
HU (1) HUP0004245A2 (zh)
ID (1) ID22878A (zh)
PL (1) PL337337A1 (zh)
WO (1) WO1998056356A1 (zh)
ZA (1) ZA984920B (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
DE60107393T2 (de) * 2000-03-01 2005-12-01 Euro-Celtique S.A. Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
WO2003086441A1 (en) * 2002-04-12 2003-10-23 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
EP1587506B1 (en) * 2002-12-18 2008-07-23 Algorx Administration of capsaicinoids
US20050020690A1 (en) * 2002-12-18 2005-01-27 Algorx Infiltration of capsaicin into surgical sites and open wounds
NZ542887A (en) * 2003-04-08 2008-05-30 Algorx Pharmaceuticals Inc Preparation and purification of synthetic capsaicin
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
CN101119713A (zh) * 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
US20080139641A1 (en) 2004-12-28 2008-06-12 Mestex Ag Use Of Resiniferatoxin (Rtx) For Producing An Agent For Treating Joint Pains And Method For Applying Said Agent
EP2096927B1 (en) 2006-10-27 2012-10-10 BMB Patent Holding Corporation Therapeutic compositions and methods of treatment with capsianoside-type compounds
WO2009029830A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Polymeric compositions and their method of use in combination with active agents
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
WO2010011597A2 (en) * 2008-07-22 2010-01-28 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
CN111494375A (zh) 2013-03-15 2020-08-07 雪松-西奈医学中心 由产甲烷菌引起或与之相关的疾病和病状的诊断、选择和治疗方法
JP2017509596A (ja) 2014-01-30 2017-04-06 オムニアクティブ ヘルス テクノロジーズ リミテッド 辛味がある油性芳香性物質の組成物およびその調製方法
CA2955666A1 (en) 2014-08-13 2016-02-18 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
WO2016161085A1 (en) * 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
WO2021011002A1 (en) * 2019-07-18 2021-01-21 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
AU2021256948A1 (en) * 2020-04-15 2022-09-01 Grünenthal GmbH Resiniferatoxin compositions
AU2022207425A1 (en) * 2021-01-15 2023-07-06 Dignify Therapeutics, Llc Compositions and methods for inducing defecation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) * 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
EP0015334B1 (en) * 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
US5063060A (en) * 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
AU4382693A (en) * 1992-05-21 1993-12-13 Jeff J. Staggs Therapeutic uses of pungent botanicals and their related compounds
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
ATE227572T1 (de) * 1995-07-14 2002-11-15 Sabinsa Corp Lebenschützende mittel, verfahren zu deren verwendung sowie extraktionsverfahren für curcuminoide

Also Published As

Publication number Publication date
GB2332147B (en) 1999-10-27
AU737606B2 (en) 2001-08-23
CN1259863A (zh) 2000-07-12
US6201014B1 (en) 2001-03-13
DE69822822D1 (de) 2004-05-06
JP2002513418A (ja) 2002-05-08
WO1998056356A1 (en) 1998-12-17
EP0988028B1 (en) 2004-03-31
EP0988028A1 (en) 2000-03-29
CN1198594C (zh) 2005-04-27
AR012960A1 (es) 2000-11-22
CA2291796A1 (en) 1998-12-17
GB9811819D0 (en) 1998-07-29
AU7782998A (en) 1998-12-30
PL337337A1 (en) 2000-08-14
CA2291796C (en) 2008-03-25
HUP0004245A2 (hu) 2001-08-28
GB9711962D0 (en) 1997-08-06
KR20010013618A (ko) 2001-02-26
ATE262892T1 (de) 2004-04-15
BR9809994A (pt) 2000-08-01
ID22878A (id) 1999-12-16
GB2332147A (en) 1999-06-16
DE69822822T2 (de) 2005-01-13
GB9827192D0 (en) 1999-02-03

Similar Documents

Publication Publication Date Title
GB2332147B (en) Therapeutically active compositions
EP1017379A4 (en) THERAPEUTIC COMPOSITIONS
GB9715751D0 (en) Formulations
HK1034663A1 (en) Topical compositions comprising ascorbyl-phosphoryl-cholesterol
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
ZA9811532B (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9705989D0 (en) Therapeutic composition
GB9711960D0 (en) Therapeutically active compositions
GB9921495D0 (en) Pharmaceutical compositions
GB9609716D0 (en) Pharmaceutically active compositions
GB9605707D0 (en) Therapeutically active compounds
GB9614757D0 (en) Therapeutically active compounds
GB9709884D0 (en) Pharmacoligically active compounds
AUPO840697A0 (en) Therapeutic compositions
GB9708183D0 (en) Pharmacologically active compound
GB9702447D0 (en) Pharmacologically active compound
GB9704275D0 (en) Pharmacologically active compound
ZA957853B (en) Therapeutically active compounds
ZA9811285B (en) New pharmaceutically active compounds
GB9703099D0 (en) Formulations
GB9703100D0 (en) Formulations